Maxine Gowen

12.7k total citations · 2 hit papers
122 papers, 10.0k citations indexed

About

Maxine Gowen is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Maxine Gowen has authored 122 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 46 papers in Oncology and 41 papers in Rheumatology. Recurrent topics in Maxine Gowen's work include Bone Metabolism and Diseases (59 papers), Bone health and treatments (29 papers) and Bone and Dental Protein Studies (21 papers). Maxine Gowen is often cited by papers focused on Bone Metabolism and Diseases (59 papers), Bone health and treatments (29 papers) and Bone and Dental Protein Studies (21 papers). Maxine Gowen collaborates with scholars based in United States, United Kingdom and Denmark. Maxine Gowen's co-authors include R.G.G. Russell, Robert A. Dodds, Gregory R. Mundy, David D. Wood, Earl J. Ihrie, Ian E. James, J. Clover, M.K.B. McGuire, Brian MacDonald and Fred H. Drake and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Maxine Gowen

122 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An interleukin 1 like factor stimulates bone resorption in vitro

1983 872 citations Maxine Gowen et al. profile →
Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts

1996 590 citations Fred H. Drake, Robert A. Dodds et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Maxine Gowen

Since Specialization

Citations

This map shows the geographic impact of Maxine Gowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxine Gowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxine Gowen more than expected).

Fields of papers citing papers by Maxine Gowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxine Gowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxine Gowen. The network helps show where Maxine Gowen may publish in the future.

Co-authorship network of co-authors of Maxine Gowen

This figure shows the co-authorship network connecting the top 25 collaborators of Maxine Gowen. A scholar is included among the top collaborators of Maxine Gowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxine Gowen. Maxine Gowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRVO27, A BETA-ARRESTIN BIASED LIGAND AT THE ANGIOTENSIN 2 TYPE 1 RECEPTOR, PRODUCES RAPID, REVERSIBLE CHANGES IN HEMODYNAMICS IN PATIENTS WITH STABLE SYSTOLIC HEART FAILURE 2013 ·Journal of the American College of Cardiology ·David G. Soergel, Ruth Ann Subach, Ian E. James, Conrad L. Cowan, Maxine Gowen, Michael W. Lark	12
2	A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys 2006 ·Bone ·Sanjay Kumar, Lauren Dare, Janice A. Vasko-Moser, Ian E. James, Simon Blake, David J. Rickard, Shing Mei Hwang, Thaddeus A. Tomaszek, Dennis S. Yamashita, Robert W. Marquis, Hye-Ja Oh, (unknown), Daniel F. Veber, Maxine Gowen, Michael W. Lark, George B. Stroup	104
3	Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agents 2001 ·Cancer Chemotherapy and Pharmacology ·Israil Pendrak, John G. Emery, Daniel P. Nadeau, Paul W. Fisher, Yuan Zhu, William D. Kingsbury, Mark Nuttall, Thema Nicholson, Larry J. Suva, Maxine Gowen	16
4	Emerging therapies in osteoporosis 2001 ·Best Practice & Research Clinical Rheumatology ·Brian MacDonald, Maxine Gowen	10
5	Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats 2000 ·Journal of Clinical Investigation ·Maxine Gowen, George B. Stroup, Robert A. Dodds, Ian E. James, Bart Votta, Brian R. Smith, Pradip K. Bhatnagar, Amparo M. Lago, James F. Callahan, Eric G. DelMar, Michael A. Miller, Edward F. Nemeth, John Fox	210
6	Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis 2000 ·Arthritis & Rheumatism ·Alison M. Badger, Don E. Griswold, Rasesh Kapadia, Simon Blake, Barbara A. Swift, (unknown), George B. Stroup, Edward F. Webb, David J. Rieman, Maxine Gowen, Jeffrey C. Boehm, Jerry L. Adams, John C. Lee	186
7	FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis 2000 ·Osteoarthritis and Cartilage ·Ian E. James, Sanjay Kumar, Michael R. Barnes, Catherine J. Gress, (unknown), Robert A. Dodds, J.R. Connor, (unknown), David A. Campbell, (unknown), (unknown), Simon Blake, Maxine Gowen, Michael W. Lark	55
8	Differential expression of Egr-1 in osteoarthritic compared to normal adult human articular cartilage 2000 ·Osteoarthritis and Cartilage ·(unknown), J.R. Connor, Robert A. Dodds, Ian E. James, Sanjay Kumar, (unknown), Michael W. Lark, Maxine Gowen, Mark Nuttall	32
9	CK?-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues 2000 ·Journal of Cellular Physiology ·Bartholomew J. Votta, John R. White, Robert A. Dodds, Ian E. James, Janice R. Connor, (unknown), (unknown), Christopher Eichman, Sanjay Kumar, Michael W. Lark, Maxine Gowen	61
10	Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization 2000 ·Osteoarthritis and Cartilage ·J.R. Connor, Robert A. Dodds, John G. Emery, Robert B. Kirkpatrick, Martin Rosenberg, Maxine Gowen	64
11	Amphibian Melanophore Technology as a Functional Screen for Antagonists of G-Protein Coupled 7-Transmembrane Receptors 1999 ·SLAS DISCOVERY ·Mark Nuttall, John C. Lee, Paul R. Murdock, Alison M. Badger, Feilan Wang, Jeffrey T. Laydon, Glenn A. Hofmann, Gary Pettman, Jonathan A. Lee, Arpana Parihar, Bradford C. Van Wagenen, John Fox, Maxine Gowen, (unknown), Michael R. Mattern	4
12	Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues 1999 ·Arthritis & Rheumatism ·Robert A. Dodds, Janice R. Connor, Fred H. Drake, Maxine Gowen	48
13	A Novel Human Bone Marrow Stroma-Derived Cell Line TF274 Is Highly Osteogenic In Vitro and In Vivo 1998 ·Calcified Tissue International ·Uma Prabhakar, Ian E. James, Robert A. Dodds, (unknown), David J. Rieman, David B. Lipshutz, (unknown), Zdenka Jonak, K. B. Tan, F H Drake, Maxine Gowen	21
14	Proteolytic Activity of Human Osteoclast Cathepsin K 1996 ·Journal of Biological Chemistry ·Mary J. Bossard, Thaddeus A. Tomaszek, Scott K. Thompson, Bernard Y. Amegadzie, Charles R. Hanning, Christopher S. Jones, (unknown), Dean E. McNulty, Fred H. Drake, Maxine Gowen, Mark A. Levy	404
15	Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? 1994 ·Bone ·J. Clover, Maxine Gowen	272
16	Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. 1994 ·Journal of Histochemistry & Cytochemistry ·Robert A. Dodds, (unknown), A.J. Littlewood, Maxine Gowen	95
17	A method for the localization of cytokine mRNA expression in adult human bone by in situ hybridization 1993 ·Bone ·Robert A. Dodds, (unknown), A.J. Littlewood, Maxine Gowen	5
18	The transcriptional control of TGF-β in human osteoblast-like cells is distinct from that of IL-1β 1992 ·Cytokine ·(unknown), Maxine Gowen	13
19	CYTOKINES AND BONE 1992 ·Lara D. Veeken ·Brian MacDonald, Maxine Gowen	62
20	Production and characterization of osteoclast-selective monoclonal antibodies that distinguish between multinucleated cells derived from different human tissues. 1991 ·Journal of Histochemistry & Cytochemistry ·Ian E. James, Susan Walsh, Robert A. Dodds, Maxine Gowen	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact